Bumi Serpong Damai Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? Bumi Serpong Damai Tbk trades at Rp555 (market cap 11.96T, 14.95M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume). The key difference: Bumi Serpong Damai Tbk is far larger — about 38.5× Diagnos Laboratorium Utama Tbk.'s market cap, and Bumi Serpong Damai Tbk is more actively traded (14.95M versus 963.6K). Which is the better fit depends on your goals.
| BSDE | DGNS | |
|---|---|---|
Market Cap | 11.96T | 310.75B |
Volume | 14.95M | 963.6K |
Lot | 149.47K | 9.64K |
Turnover | 8.38B | 217.67M |
Average Price | 560.76 | 225.89 |
Value | 8.38B | 217.67M |
Indicative Equilibrium Price | 555 | 226 |
Indicative Equilibrium Volume | 1.58K | 1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Bumi Serpong Damai Tbk (the company) was established on January 16, 1984 based on the Notarial Deed No. 50 of Benny Kristianto, S.H., a public notary in Jakarta. The Company’s articles of association has been amended several times, most recently by notarial deed No. 01 of Tarwiyah, S.H., dated Jan 25, 2008, concerning company's public offering.
Read more on BSDE →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →